GE HealthCare Technologies Inc. Ratios | P/E, ROE & Valuation

On the Key Ratios page for GE HealthCare Technologies Inc. (GEHC), the latest P/E of 20.3 frames valuation, while ROE 15.16% and ROIC 8.15% indicates profitability and capital efficiency. Together with the current ratio of 1.02 and debt-to-equity 0.92, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

GEHC Historical Per Share Metrics

7 years
Metric (FY)TTM202420232022202120202019
Revenue per Share$44.69$43.14$42.97$40.41$38.67$37.75$36.58
Net Income per Share$3.51$4.37$3.45$4.22$4.94$30.45$3.35
Operating Cash Flow per Share$3.13$4.28$4.62$4.65$3.53$3.71$4.37
Free Cash Flow per Share$1.98$3.40$3.77$3.97$2.99$3.14$3.65
Cash per Share$4.65$6.34$5.50$3.18$1.22$2.21$0.00
Book Value per Share$24.26$18.98$16.07$21.13$37.16$32.93$0.00
Tangible Book Value per Share$-13.24$-12.20$-15.12$-10.44$4.74$3.31$0.00
Interest Debt per Share$23.24$21.67$22.87$19.21$1.05$1.17$0.00
CAPEX per Share$1.15$0.88$0.85$0.68$0.55$0.57$0.73

GEHC Historical Valuation Ratios

7 years
Metric (FY)TTM202420232022202120202019
Price to Earnings (P/E)20.2817.8922.4413.8312.141.9717.9
Price to Book (P/B)2.914.224.932.831.641.850
Price to Sales (P/S)1.571.811.81.441.551.591.64
Enterprise Value to EBITDA11.4711.4912.1110.647.677.850
EV to Sales1.972.142.181.841.541.560
EV to Operating Cash Flow28.1321.620.2515.9416.915.850
EV to Free Cash Flow44.5427.1824.8218.6919.9918.730
Enterprise Value$39.86B$42.14B$42.54B$33.69B$27.16B$26.74B$0.00

GEHC Historical Profitability Ratios

7 years
Metric (FY)TTM202420232022202120202019
Return on Equity (ROE)15.16%23.59%21.98%20.48%13.49%94.02%0.00%
Return on Invested Capital (ROIC)8.15%8.29%6.79%9.56%11.25%11.58%0.00%
Return on Tangible Assets7.86%10.56%8.58%14.51%19.42%128.72%0.00%
Earnings Yield4.98%5.59%4.46%7.23%8.24%50.75%5.59%
Free Cash Flow Yield2.81%4.35%4.87%6.80%4.98%5.23%6.08%
Dividend Yield0.20%0.15%0.12%0.00%0.00%0.00%0.00%

GEHC Historical Liquidity & Financial Strength

7 years
Metric (FY)TTM202420232022202120202019
Current Ratio1.02111.090.970.840
Interest Coverage5.95.24.4929.3369.8841.2124.14
Income Quality0.70.951.31.080.710.821.18
Debt to Equity0.921.111.380.920.030.030
Debt to Assets27.10%28.34%30.39%31.36%1.66%1.93%0.00%
Net Debt to EBITDA2.31.772.092.27-0.03-0.160

GEHC Historical Efficiency Ratios

7 years
Metric (FY)TTM202420232022202120202019
Receivables Turnover5.224.54.534.594.646.460
Payables Turnover3.583.793.953.613.814.360
Inventory Turnover4.655.915.935.185.356.520
Days Sales Outstanding69.9881.1980.5579.4678.6956.50
Days Payables Outstanding102.0596.1992.49101.0495.6883.80
Days of Inventory on Hand78.4361.7261.5170.4768.2255.960

GEHC Historical Market Metrics

7 years
Metric (FY)TTM202420232022202120202019
Enterprise Value to EBITDA11.4711.4912.1110.647.677.850
Market Cap$31.87B$35.65B$35.18B$26.50B$27.28B$27.28B$27.28B
Enterprise Value$39.86B$42.14B$42.54B$33.69B$27.16B$26.74B$0.00
Dividend Yield0.20%0.15%0.12%0.00%0.00%0.00%0.00%
Payout Ratio4.02%2.76%2.61%0.00%0.00%0.00%0.00%

Frequently Asked Questions

How does GE HealthCare Technologies Inc.’s P/E ratio compare with its history?

On this page, GEHC's current P/E is 20.3, compared with a multi-year average around 15.2. A higher P/E versus its own history is a calculated premium versus that average—not a conclusion that the stock is expensive. Cross-check profitability (ROE/ROIC), liquidity (current ratio), and leverage (debt-to-equity) so the multiple is read with those published figures.

What is GE HealthCare Technologies Inc. market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $31.87B. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does GE HealthCare Technologies Inc.’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with GE HealthCare Technologies Inc.'s own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does GE HealthCare Technologies Inc. compare to its competitors in key financial ratios?

The fastest way to compare GE HealthCare Technologies Inc. with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see GE HealthCare Technologies Inc. outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do GE HealthCare Technologies Inc.'s liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that GE HealthCare Technologies Inc. is financially strong. Current ratio is about 1.02, which is above 1.0 and can indicate more comfortable short-term liquidity. Interest coverage is about 5.90, implying a stronger ability to cover interest expenses. Debt-to-equity is about 0.92, suggesting leverage is more moderate relative to a high-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do GE HealthCare Technologies Inc.'s financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If GE HealthCare Technologies Inc. is sustaining strong returns (for example ROE at 15.16% and ROIC at 8.15%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.